IndiaOne Finance - Company Dashboard

Governance Classic Home

Anthem Biosciences LtdBiotechnologyINE0CZ201020Consolidated₹933.75+7.20 (+0.78%)Jun-26

Valuation

Market Cap₹52.31K Cr

TTM PE90.67x

Forward PE97.42x

PEG-31.81

Book Value₹54.00

P/B17.19x

TTM EPS₹10.24

Fwd EPS₹9.53

TTM Revenue₹2.00K Cr

TTM PAT₹575.95 Cr

TTM EBITDA₹792.88 Cr

TTM EBIT₹655.27 Cr

Last Qtr PAT₹119.94 Cr

Last Qtr EBITDA₹150.57 Cr

Last Qtr EBIT₹120.58 Cr

Profitability

ROE18.93%

ROCE25.47%

TTM NPM28.76%

TTM EBITDA %39.60%

Curr OPM27.07%

Last OPM28.66%

Curr NPM—

Last NPM—

Curr EPS₹2.13

Last EPS₹3.37

Balance sheet

Equity₹112.34 Cr

Reserve₹2.93K Cr

Total Debt₹53.91 Cr

D/E0.02x

Interest %0.74%

Curr Interest₹0.89 Cr

Price / range

Close₹928.50

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.12%

1W-0.90%

1M+4.84%

3M+17.01%

6M+44.05%

1Y+8.60%

2Y—

3Y—

5Y—

Diwali+45.31%

Sector peers — Biotechnology

Company	Close	Mkt Cap	TTM P/E	ROE
ANTHEM	928.50	₹52.31K Cr	90.67	18.93%
ADVENZYMES	287.80	₹3.22K Cr	19.46	—
GENESIS	36.45	₹164.94 Cr	-72.90	—
VIVOBIOT	16.71	₹37.08 Cr	6.85	—
SHREEGANES	0.48	₹19.13 Cr	—	—
GVBL	28.73	₹8.78 Cr	478.83	—

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	383.84-28.7%	582.50	416.58	552.23	538.01	2,089.31
Other Income	28.60	60.63	39.92	53.80	27.73	182.08
Total Income	412.44-27.1%	643.13	456.50	606.03	565.74	2,271.39
Interest	0.76	1.58	1.13	2.23	1.61	6.55
Expenditure	-276.08+24.7%	-343.38	-281.40	-352.72	-366.80	-1,344.31
PBDT	0	0	0	0	0	0
EBITDA	130.83-33.1%	266.98	163.06	225.66	195.43	851.12
Depreciation	-22.31	-26.28	-26.75	-23.92	-22.61	-99.57
EBIT	108.52-37.2%	240.70	136.31	201.74	172.82	751.55
PBT	136.36-31.5%	300.72	150.11	253.30	198.94	903.07
Tax	-34.35	-89.06	-37.99	-54.87	-50.50	-232.51
Equity	112.68	112.34	112.32	0	0	112.34
OPM	33.06	46.76	32.88	45.87	36.98	39.76
Net Profit	102.01-31.2%	211.66	112.12	198.43	148.34	670.56
NPM	24.73	32.91	24.56	35.93	27.57	29.52
EPS	1.81	3.77	2	3.54	0	11.95

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	2,089.31
Other Income	182.08
Total Income	2,271.39
Expenditure	-1,344.31
Interest	-6.55
PBDT	0
EBITDA	851.12
Depreciation	-99.57
EBIT	751.55
PBT	903.07
Tax	-232.51
Equity	112.34
OPM (%)	39.76
Net Profit	670.56
NPM (%)	29.52
EPS (Rs)	11.95
CEPS	11.82

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	418.22-22.6%	610.94	423.15	550.03	540.21	2,124.33
Other Income	24.89	51.21	33.53	48.23	22.81	155.78
Total Income	443.11-21.3%	662.16	456.68	598.26	563.02	2,280.12
Interest	0.89	1.90	0.35	3.03	1.61	6.89
Expenditure	-298.53+20.8%	-385.22	-300.84	-368.65	-376.70	-1,431.49
PBDT	0	0	0	0	0	0
EBITDA	150.57-21.4%	267.21	157.19	217.91	191.57	833.80
Depreciation	-29.99	-39.59	-34.53	-33.50	-26.45	-134.07
EBIT	120.58-27.0%	227.62	122.66	184.41	165.12	699.73
PBT	144.58-22.4%	277.92	130.47	229.60	186.25	824.24
Tax	-24.64	-88.16	-37.66	-56.17	-50.40	-232.45
Equity	112.68	112.34	112.32	0	0	112.34
OPM	32.63	41.97	28.57	38.38	33.08	36.15
Net Profit	119.94-11.7%	189.76	92.82	173.43	135.79	591.79
NPM	27.07	28.66	20.32	28.99	24.12	25.95
EPS	2.13-12.3%	0	1.65	3.09	2.43	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	2,124.33
Other Income	155.78
Total Income	2,280.12
Expenditure	-1,431.49
Interest	-6.89
PBDT	0
EBITDA	833.80
Depreciation	-134.07
EBIT	699.73
PBT	824.24
Tax	-232.45
Equity	112.34
OPM (%)	36.15
Net Profit	591.79
NPM (%)	25.95
EPS (Rs)	0
CEPS	0

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	2	25 Jun 2026

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split